- Home
- GLQ vs CBUS Comparison
GLQ vs CBUS Comparison
Compare GLQ & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GLQ | CBUS |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.2M | 142.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | GLQ | CBUS |
|---|---|---|
| Price | $7.94 | $1.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 35.7K | ★ 119.5K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 11.11% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.27 | $1.09 |
| 52 Week High | $8.75 | $4.19 |
Technical Indicators
Market Signals| Indicator | GLQ | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 42.93 |
| Support Level | $7.65 | $1.49 |
| Resistance Level | $8.18 | $1.82 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 13.96 | 41.51 |
Price Performance
Historical ComparisonAbout GLQ Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest
Clough Global Equity Fund is a closed-end management investment company. Its investment objective is to provide a high level of total return. The Fund invests in the equity, equity-related securities, and fixed-income securities in both U.S. and non-U.S. markets.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.